Not applicableStudy completedNCT02620254What this trial is testingMast Cell Connect: A Registry for Patients With MastocytosisWho this might be right forMastocytosis Blueprint Medicines Corporation 743
Testing effectiveness (Phase 2)Study completedNCT00831974What this trial is testingEfficacy of AB1010 in Patients With Systemic Indolent MastocytosisWho this might be right forMastocytosis AB Science 23
Not applicableUnknownNCT06210698What this trial is testingAngioedema Biomarker Research StudyWho this might be right forAngioedemaAngioedemas, HereditaryUrticaria+5 more Foundation For Rare Disease Research 600
Testing effectiveness (Phase 2)Active Not RecruitingNCT05186753What this trial is testing(Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic MastocytosisWho this might be right forSSMMastocytosis, IndolentMastocytosis, Systemic+5 more Cogent Biosciences, Inc. 237
Testing effectiveness (Phase 2)Study completedNCT03770273What this trial is testingSafety and Efficacy of Subcutaneous Sarilumab in Improving the Quality of Life in People With Indolent Systemic MastocytosisWho this might be right forIndolent Systemic Mastocytosis National Institute of Allergy and Infectious Diseases (NIAID) 21
Not applicableUnknownNCT05923372What this trial is testingEvaluation of the DALY on a Cohort of Patients With Indolent Systemic MastocytosisWho this might be right forMastocytosis, Indolent Systemic University Hospital, Toulouse 160
Testing effectiveness (Phase 2)Active Not RecruitingNCT03731260What this trial is testing(PIONEER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, Versus Placebo in Patients With Indolent Systemic MastocytosisWho this might be right forIndolent Systemic Mastocytosis Blueprint Medicines Corporation 251
Not applicableNot Yet RecruitingNCT07264959What this trial is testingAn Observational Study in Participants With Indolent Systemic Mastocytosis (ISM)Who this might be right forIndolent Systemic Mastocytosis Blueprint Medicines Corporation 150
Testing effectiveness (Phase 2)Study completedNCT02478957What this trial is testingTreatment of Indolent Systemic Mastocytosis With PA101Who this might be right forMastocytosisSystemic MastocytosisIndolent Systemic Mastocytosis Patara Pharma 41
Not applicableStudy completedNCT03632811What this trial is testingAdaptation of the Questionnaire "Regarding Patient's Quality of Life With Mastocytosis" in the French LanguageWho this might be right forCutaneous MastocytosisIndolent Systemic Mastocytosis University Hospital, Toulouse 30
Large-scale testing (Phase 3)Looking for participantsNCT04910685What this trial is testing(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic MastocytosisWho this might be right forIndolent Systemic MastocytosisSmoldering Systemic Mastocytosis Blueprint Medicines Corporation 534
Not applicableStudy completedNCT02380222What this trial is testingPatient-Reported Outcome Questionnaire for Systemic MastocytosisWho this might be right forAggressive Systemic Mastocytosis (ASM)SM w Assoc Clonal Hema Non-mast Cell Lineage Disease (SM-AHNMD)Mast Cell Leukemia (MCL)+2 more Adelphi Values LLC 5
Testing effectiveness (Phase 2)UnknownNCT01920204What this trial is testingMidostaurin in Indolent Systemic MastocytosisWho this might be right forIndolent Systemic Mastocytosis University Medical Center Groningen 20
Not applicableLooking for participantsNCT07255638What this trial is testingA Non-Interventional Study in Participants With Indolent Systemic Mastocytosis (ISM) in GermanyWho this might be right forIndolent Systemic Mastocytosis Blueprint Medicines Corporation 80
Large-scale testing (Phase 3)Study completedNCT00814073What this trial is testingMasitinib in Severe Indolent or Smoldering Systemic MastocytosisWho this might be right forIndolent Systemic Mastocytosis AB Science 135
Not applicableAvailableNCT06915766What this trial is testingExpanded Access to Bezuclastinib for Patients With NonAdvanced Systemic Mastocytosis or Advanced Systemic MastocytosisWho this might be right forSystemic Mastocytoses, IndolentSystemic Mastocytoses, Aggressive Cogent Biosciences, Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT04655118What this trial is testingStudy of TL-895 in Subjects With Myelofibrosis or Indolent Systemic MastocytosisWho this might be right forMyelofibrosisIndolent Systemic Mastocytosis Telios Pharma, Inc. 121
Large-scale testing (Phase 3)UnknownNCT04333108What this trial is testingMasitinib in Severe Indolent or Smoldering Systemic Mastocytosis Unresponsive to Optimal Symptomatic TreatmentWho this might be right forIndolent Systemic Mastocytosis AB Science 140
Large-scale testing (Phase 3)UnknownNCT05084872What this trial is testingHydroxychloroquine in Isolated Cutaneous Mastocytosis Patients or Indolent Systemic Mastocytosis With Associated Skin Involvement PatientsWho this might be right forMastocytosis University Hospital, Toulouse 30
Early research (Phase 1)Study completedNCT02808793What this trial is testingEvaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AK002Who this might be right forIndolent Systemic Mastocytosis Allakos Inc. 25